Predictive biomarkers with isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma

Detalles Bibliográficos
Autores principales: Richardson, Paul G., Facon, Thierry, Bensinger, William I., Leleu, Xavier, Campana, Frank, Macé, Sandrine, Chiron, Marielle, van de Velde, Helgi, Mikhael, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954817/
https://www.ncbi.nlm.nih.gov/pubmed/33712562
http://dx.doi.org/10.1038/s41408-021-00438-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954817/
https://www.ncbi.nlm.nih.gov/pubmed/33712562
http://dx.doi.org/10.1038/s41408-021-00438-y

Ejemplares similares